{
    "name": "liotrix",
    "comment": "Rx",
    "other_names": [
        "Thyrolar"
    ],
    "classes": [
        "Thyroid Products"
    ],
    "source": "https://reference.medscape.com/drug/thyrolar-liotrix-342737",
    "pregnancy": {
        "common": [
            "Pregnancy Category: A",
            "Lactation: Small amount excreted into breast milk, use caution"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Small amount excreted into breast milk, use caution"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [
                "Thyroid hormones, either alone or with other therapeutic agents, should not be used for the treatment of obesity or for weight loss",
                "In euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction. Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for their anorectic effects."
            ],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to thyroid hormone",
                "Acute MI uncomplicated by hypothyroidism, untreated thyrotoxicosis, untreated adrenal insufficiency",
                "Treatment of obesity"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Caution in angina, cardiovascular disease, HTN, endocrine disorders, elderly",
                "Use caution in patients with adrenal insufficiency (symptoms may become exagerated or aggravated)",
                "Euthroid withdrawn from U.S. market",
                "Use caution in patients with myxedema (symptoms may become exagerated or aggravated)",
                "No advantage over levothyroxine & may do more harm (T3 overdosage) than good",
                "Not for the treatment of female infertility in euthyroid patients"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Contraindicated",
            "interaction_with": "sodium iodide I-131",
            "description": {
                "common": "liotrix will decrease the level or effect of sodium iodide I-131 by  Other (see comment). Contraindicated. Use of thyroid products or iodine before and during treatment with sodium iodide I-131 decreases uptake of sodium iodide I-131 by the thyroid gland"
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "amitriptyline",
            "description": {
                "common": "liotrix increases effects of amitriptyline by Other (see comment). Use Caution/Monitor. \nComment: Increased catecholamine receptor sensitivity; may increase CNS and cardiovascular effects, including arrhythmias."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "amoxapine",
            "description": {
                "common": "liotrix increases effects of amoxapine by Other (see comment). Use Caution/Monitor. \nComment: Increased catecholamine receptor sensitivity; may increase CNS and cardiovascular effects, including arrhythmias."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "clomipramine",
            "description": {
                "common": "liotrix increases effects of clomipramine by Other (see comment). Use Caution/Monitor. \nComment: Increased catecholamine receptor sensitivity; may increase CNS and cardiovascular effects, including arrhythmias."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "desipramine",
            "description": {
                "common": "liotrix increases effects of desipramine by Other (see comment). Use Caution/Monitor. \nComment: Increased catecholamine receptor sensitivity; may increase CNS and cardiovascular effects, including arrhythmias."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "didanosine",
            "description": {
                "common": "didanosine will decrease the level or effect of liotrix by  inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor. Applies to didanosine chewable tablets and powder for oral solution; administer 2 hr before or several hours after didanosine oral solution or chewable tablet administration"
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "doxepin",
            "description": {
                "common": "liotrix increases effects of doxepin by Other (see comment). Use Caution/Monitor. \nComment: Increased catecholamine receptor sensitivity; may increase CNS and cardiovascular effects, including arrhythmias."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "doxepin cream",
            "description": {
                "common": "liotrix increases effects of doxepin cream by Other (see comment). Use Caution/Monitor. \nComment: Increased catecholamine receptor sensitivity; may increase CNS and cardiovascular effects, including arrhythmias."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "imipramine",
            "description": {
                "common": "liotrix increases effects of imipramine by Other (see comment). Use Caution/Monitor. \nComment: Increased catecholamine receptor sensitivity; may increase CNS and cardiovascular effects, including arrhythmias."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "insulin degludec",
            "description": {
                "common": "liotrix decreases effects of insulin degludec by pharmacodynamic antagonism. Use Caution/Monitor. Thyroid hormones regulate carbohydrate metabolism, gluconeogenesis, and glycogen stores mobilization; dose of antidiabetic agents may need adjustment and increased frequency of glucose monitoring may be required."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "insulin degludec/insulin aspart",
            "description": {
                "common": "liotrix decreases effects of insulin degludec/insulin aspart by pharmacodynamic antagonism. Use Caution/Monitor. Thyroid hormones regulate carbohydrate metabolism, gluconeogenesis, and glycogen stores mobilization; dose of antidiabetic agents may need adjustment and increased frequency of glucose monitoring may be required."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "insulin inhaled",
            "description": {
                "common": "liotrix decreases effects of insulin inhaled by pharmacodynamic antagonism. Use Caution/Monitor. Thyroid hormones regulate carbohydrate metabolism, gluconeogenesis, and glycogen stores mobilization; dose of antidiabetic agents may need adjustment and increased frequency of glucose monitoring may be required."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "lanthanum carbonate",
            "description": {
                "common": "lanthanum carbonate decreases levels of liotrix by cation binding in GI tract. Use Caution/Monitor. Administer oral thyroid products at least 2 hr before or after lanthanum. Interaction applies only to oral thyroid products only. ."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "levonorgestrel oral/ethinylestradiol/ferrous bisglycinate",
            "description": {
                "common": "levonorgestrel oral/ethinylestradiol/ferrous bisglycinate will decrease the level or effect of liotrix by  unknown mechanism. Modify Therapy/Monitor Closely. The estrogen component of combined hormonal contraceptives (CHCs) may raise the serum concentrations of thyroxine-binding globulin. Women on thyroid hormone replacement therapy may need increased doses of thyroid hormone with use of CHCs."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "metformin",
            "description": {
                "common": "liotrix decreases effects of metformin by pharmacodynamic antagonism. Use Caution/Monitor. Patient should be closely observed for loss of blood glucose control; when drugs are withdrawn from a patient receiving metformin, patient should be observed closely for hypoglycemia."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "nateglinide",
            "description": {
                "common": "liotrix decreases effects of nateglinide by pharmacodynamic antagonism. Use Caution/Monitor. Coadministration may reduce nateglinide's hypoglycemic action."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "nortriptyline",
            "description": {
                "common": "liotrix increases effects of nortriptyline by Other (see comment). Use Caution/Monitor. \nComment: Increased catecholamine receptor sensitivity; may increase CNS and cardiovascular effects, including arrhythmias."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "protriptyline",
            "description": {
                "common": "liotrix increases effects of protriptyline by Other (see comment). Use Caution/Monitor. \nComment: Increased catecholamine receptor sensitivity; may increase CNS and cardiovascular effects, including arrhythmias."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "trimipramine",
            "description": {
                "common": "liotrix increases effects of trimipramine by Other (see comment). Use Caution/Monitor. \nComment: Increased catecholamine receptor sensitivity; may increase CNS and cardiovascular effects, including arrhythmias."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "warfarin",
            "description": {
                "common": "liotrix increases effects of warfarin by unspecified interaction mechanism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "dexlansoprazole",
            "description": {
                "common": "dexlansoprazole decreases levels of liotrix by increasing gastric pH. Applies only to oral form of both agents. Minor/Significance Unknown. Conflicting evidence regarding this interaction exists."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "esomeprazole",
            "description": {
                "common": "esomeprazole decreases levels of liotrix by increasing gastric pH. Applies only to oral form of both agents. Minor/Significance Unknown. Conflicting evidence regarding this interaction exists."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "furosemide",
            "description": {
                "common": "furosemide increases toxicity of liotrix by Other (see comment). Minor/Significance Unknown. \nComment: High doses (greater than 80 mg) of furosemide may inhibit binding of thyroid hormones to carrier proteins and result in transient increase in free thyroid hormones, followed by overall decrease in total thyroid hormone levels."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "lansoprazole",
            "description": {
                "common": "lansoprazole decreases levels of liotrix by increasing gastric pH. Applies only to oral form of both agents. Minor/Significance Unknown. Conflicting evidence regarding this interaction exists."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "omeprazole",
            "description": {
                "common": "omeprazole decreases levels of liotrix by increasing gastric pH. Applies only to oral form of both agents. Minor/Significance Unknown. Conflicting evidence regarding this interaction exists."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "pantoprazole",
            "description": {
                "common": "pantoprazole decreases levels of liotrix by increasing gastric pH. Applies only to oral form of both agents. Minor/Significance Unknown. Conflicting evidence regarding this interaction exists."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "rabeprazole",
            "description": {
                "common": "rabeprazole decreases levels of liotrix by increasing gastric pH. Applies only to oral form of both agents. Minor/Significance Unknown. Conflicting evidence regarding this interaction exists."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Arrhythmias",
            "percent": null
        },
        {
            "name": "Increased blood pressure",
            "percent": null
        },
        {
            "name": "Chest pain",
            "percent": null
        },
        {
            "name": "Palpitation",
            "percent": null
        },
        {
            "name": "Anxiety",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Urticaria",
            "percent": null
        },
        {
            "name": "Changes in menstrual cycle",
            "percent": null
        },
        {
            "name": "Insomnia",
            "percent": null
        },
        {
            "name": "Hyperhydrosis pruritus",
            "percent": null
        },
        {
            "name": "Tachycardia",
            "percent": null
        },
        {
            "name": "Nervousness",
            "percent": null
        },
        {
            "name": "Tremor",
            "percent": null
        },
        {
            "name": "Cramps",
            "percent": null
        },
        {
            "name": "Increased appetite",
            "percent": null
        },
        {
            "name": "Weight loss",
            "percent": null
        },
        {
            "name": "Diarrhea",
            "percent": null
        }
    ]
}